Five years ago, Immunocore Ltd. broke a European biotech fundraising record when it raised a hefty $320m in its debut funding round, and looked set to be a real contender among emerging immunotherapy companies.
Fast forward to 2020, and the Oxford, UK-headquartered firm has precious little to show from that series A capital, having...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

